Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiretroviral Therapy
Hui Zhang, M.D., Ph.D., Geethanjali Dornadula, Ph.D., Maria Beumont, M.D., Lawrence Livornese, M.D., Bonnie Van Uitert, M.D., Kelly Henning, M.D., and Roger J. Pomerantz, M.D.
Background Highly active antiretroviral therapy can effectivelydecrease the levels of human immunodeficiency virus type 1 (HIV-1)virions in peripheral plasma and seminal fluid of infected men.Whether the genital tract of HIV-1infected men who arereceiving highly active antiretroviral therapy and who haveno detectable virus in the peripheral plasma harbors replication-competentvirus is not known.
Methods We collected peripheral-blood and semen samples fromseven men with HIV-1 infection who were receiving highly activeantiretroviral therapy and who had no detectable viral RNA (fewerthan 50 copies per milliliter) in plasma and analyzed the samplesfor cell-associated proviral DNA using a quantitative polymerase-chain-reactionassay. Replication-competent viruses were evaluated by cell-cocultureassays. Proviral DNA and replication-competent virus obtainedfrom peripheral-blood and seminal cells were also analyzed bysequencing relevant viral genes.
Results Despite the long-term suppression of HIV-1 RNA in theplasma of the seven men, proviral DNA was detected in seminalcells in four. Replication-competent viruses were recoveredfrom peripheral-blood cells in three men and from the seminalcells in two of these three men. The viruses recovered fromthe seminal cells had no genotypic mutations suggestive of resistanceto antiretroviral drugs and were macrophage-tropic, a featurethat is characteristic of HIV-1 strains that are capable ofbeing sexually transmitted.
Conclusions In HIV-1infected men who are receiving highlyactive antiretroviral therapy and who have no detectable levelsof viral RNA in plasma, the virus may be present in seminalcells and therefore may be capable of being transmitted sexually.
Source Information
From the Dorrance H. Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, 1020 Locust St., Suite 329, Philadelphia, PA 19107, where reprint requests should be addressed to Dr. Pomerantz.
Jung, N., Lehmann, C., Rubbert, A., Knispel, M., Hartmann, P., van Lunzen, J., Stellbrink, H.-J., Faetkenheuer, G., Taubert, D.
(2008). Relevance of the Organic Cation Transporters 1 and 2 for Antiretroviral Drug Therapy in Human Immunodeficiency Virus Infection. Drug Metab. Dispos.
36: 1616-1623
[Abstract][Full Text]
Taiwo, B. O., Murphy, R.
(2007). Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings. J Int Assoc Physicians AIDS Care (Chic Ill)
6: 188-197
[Abstract]
Barreiro, P., Castilla, J. A., Labarga, P., Soriano, V.
(2007). Is natural conception a valid option for HIV-serodiscordant couples?. Hum Reprod
22: 2353-2358
[Abstract][Full Text]
van Leeuwen, E., Prins, J.M., Jurriaans, S., Boer, K., Reiss, P., Repping, S., van der Veen, F.
(2007). Reproduction and fertility in human immunodeficiency virus type-1 infection. Hum Reprod Update
13: 197-206
[Abstract][Full Text]
van Leeuwen, E., ter Heine, R., van der Veen, F., Repping, S., Beijnen, J. H., Prins, J. M.
(2007). Penetration of Atazanavir in Seminal Plasma of Men Infected with Human Immunodeficiency Virus Type 1. Antimicrob. Agents Chemother.
51: 335-337
[Abstract][Full Text]
Roulet, V., Satie, A.-P., Ruffault, A., Tortorec, A. L., Denis, H., Guist'hau, O., Patard, J.-J., Rioux-Leclerq, N., Gicquel, J., Jegou, B., Dejucq-Rainsford, N.
(2006). Susceptibility of Human Testis to Human Immunodeficiency Virus-1 Infection in Situ and in Vitro. Am. J. Pathol.
169: 2094-2103
[Abstract][Full Text]
Manigart, Y., Rozenberg, S., Barlow, P., Gerard, M., Bertrand, E., Delvigne, A.
(2006). ART outcome in HIV-infected patients. Hum Reprod
21: 2935-2940
[Abstract][Full Text]
D'Cruz, O. J., Uckun, F. M.
(2006). Dawn of non-nucleoside inhibitor-based anti-HIV microbicides. J Antimicrob Chemother
57: 411-423
[Abstract][Full Text]
McClelland, R. S., Baeten, J. M.
(2006). Reducing HIV-1 transmission through prevention strategies targeting HIV-1-seropositive individuals. J Antimicrob Chemother
57: 163-166
[Abstract][Full Text]
Volberding, P. A.
(2005). The New York Case: Lessons Being Learned. ANN INTERN MED
142: 866-868
[Full Text]
Lee, W. A., He, G.-X., Eisenberg, E., Cihlar, T., Swaminathan, S., Mulato, A., Cundy, K. C.
(2005). Selective Intracellular Activation of a Novel Prodrug of the Human Immunodeficiency Virus Reverse Transcriptase Inhibitor Tenofovir Leads to Preferential Distribution and Accumulation in Lymphatic Tissue. Antimicrob. Agents Chemother.
49: 1898-1906
[Abstract][Full Text]
Pillai, S. K., Good, B., Pond, S. K., Wong, J. K., Strain, M. C., Richman, D. D., Smith, D. M.
(2005). Semen-Specific Genetic Characteristics of Human Immunodeficiency Virus Type 1 env. J. Virol.
79: 1734-1742
[Abstract][Full Text]
Fichorova, R. N., Zhou, F., Ratnam, V., Atanassova, V., Jiang, S., Strick, N., Neurath, A. R.
(2005). Anti-Human Immunodeficiency Virus Type 1 Microbicide Cellulose Acetate 1,2-Benzenedicarboxylate in a Human In Vitro Model of Vaginal Inflammation. Antimicrob. Agents Chemother.
49: 323-335
[Abstract][Full Text]
Dezzutti, C. S., James, V. N., Ramos, A., Sullivan, S. T., Siddig, A., Bush, T. J., Grohskopf, L. A., Paxton, L., Subbarao, S., Hart, C. E.
(2004). In Vitro Comparison of Topical Microbicides for Prevention of Human Immunodeficiency Virus Type 1 Transmission. Antimicrob. Agents Chemother.
48: 3834-3844
[Abstract][Full Text]
Crepaz, N., Hart, T. A., Marks, G.
(2004). Highly Active Antiretroviral Therapy and Sexual Risk Behavior: A Meta-analytic Review. JAMA
292: 224-236
[Abstract][Full Text]
Stebbing, J., Gazzard, B., Douek, D. C.
(2004). Where Does HIV Live?. NEJM
350: 1872-1880
[Full Text]
Englert, Y., Lesage, B., Van Vooren, J.-P., Liesnard, C., Place, I., Vannin, A.-S., Emiliani, S., Delbaere, A.
(2004). Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update
10: 149-162
[Abstract][Full Text]
Van Herrewege, Y., Michiels, J., Van Roey, J., Fransen, K., Kestens, L., Balzarini, J., Lewi, P., Vanham, G., Janssen, P.
(2004). In Vitro Evaluation of Nonnucleoside Reverse Transcriptase Inhibitors UC-781 and TMC120-R147681 as Human Immunodeficiency Virus Microbicides. Antimicrob. Agents Chemother.
48: 337-339
[Abstract][Full Text]
D'Cruz, O. J., Samuel, P., Waurzyniak, B., Uckun, F. M.
(2003). Development and Evaluation of a Thermoreversible Ovule Formulation of Stampidine, a Novel Nonspermicidal Broad-Spectrum Anti-Human Immunodeficiency Virus Microbicide. Biol. Reprod.
69: 1843-1851
[Abstract][Full Text]
Argyris, E. G., Acheampong, E., Nunnari, G., Mukhtar, M., Williams, K. J., Pomerantz, R. J.
(2003). Human Immunodeficiency Virus Type 1 Enters Primary Human Brain Microvascular Endothelial Cells by a Mechanism Involving Cell Surface Proteoglycans Independent of Lipid Rafts. J. Virol.
77: 12140-12151
[Abstract][Full Text]
D'Cruz, O. J., Erbeck, D., Uckun, F. M.
(2003). Developmental Toxicology Studies of WHI-07, a Novel Nucleoside Analogue-Based Dual-Function Microbicide, Administered Intravaginally to Rabbits. Toxicol Pathol
31: 698-708
[Abstract]
Ohl, J., Partisani, M., Wittemer, C., Schmitt, M.-P., Cranz, C., Stoll-Keller, F., Rongieres, C., Bettahar-Lebugle, K., Lang, J.-M., Nisand, I.
(2003). Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience. Hum Reprod
18: 1244-1249
[Abstract][Full Text]
von Lindern, J. J., Rojo, D., Grovit-Ferbas, K., Yeramian, C., Deng, C., Herbein, G., Ferguson, M. R., Pappas, T. C., Decker, J. M., Singh, A., Collman, R. G., O'Brien, W. A.
(2003). Potential Role for CD63 in CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection of Macrophages. J. Virol.
77: 3624-3633
[Abstract][Full Text]
Yang, B., Gao, L., Li, L., Lu, Z., Fan, X., Patel, C. A., Pomerantz, R. J., DuBois, G. C., Zhang, H.
(2003). Potent Suppression of Viral Infectivity by the Peptides That Inhibit Multimerization of Human Immunodeficiency Virus Type 1 (HIV-1) Vif Proteins. J. Biol. Chem.
278: 6596-6602
[Abstract][Full Text]
Di Mascio, M., Dornadula, G., Zhang, H., Sullivan, J., Xu, Y., Kulkosky, J., Pomerantz, R. J., Perelson, A. S.
(2003). In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 Months. J. Virol.
77: 2271-2275
[Abstract][Full Text]
Letur-Konirsch, H., Collin, G., Sifer, C., Devaux, A., Kuttenn, F., Madelenat, P., Brun-Vezinet, F., Feldmann, G., Benifla, J.-L.
(2003). Safety of cryopreservation straws for human gametes or embryos: a study with human immunodeficiency virus-1 under cryopreservation conditions. Hum Reprod
18: 140-144
[Abstract][Full Text]
Musey, L., Ding, Y., Cao, J., Lee, J., Galloway, C., Yuen, A., Jerome, K. R., McElrath, M. J.
(2002). Ontogeny and Specificities of Mucosal and Blood Human Immunodeficiency Virus Type 1-Specific CD8+ Cytotoxic T Lymphocytes. J. Virol.
77: 291-300
[Abstract][Full Text]
D'Cruz, O. J., Uckun, F. M.
(2002). Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and WHI-07). J Antimicrob Chemother
50: 793-803
[Abstract][Full Text]
Kostrikis, L. G., Touloumi, G., Karanicolas, R., Pantazis, N., Anastassopoulou, C., Karafoulidou, A., Goedert, J. J., Hatzakis, A.
(2002). Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load. J. Virol.
76: 10099-10108
[Abstract][Full Text]
Gupta, P., Collins, K. B., Ratner, D., Watkins, S., Naus, G. J., Landers, D. V., Patterson, B. K.
(2002). Memory CD4+ T Cells Are the Earliest Detectable Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Cells in the Female Genital Mucosal Tissue during HIV-1 Transmission in an Organ Culture System. J. Virol.
76: 9868-9876
[Abstract][Full Text]
Dulioust, E., Du, A.L., Costagliola, D., Guibert, J., Kunstmann, J.-M., Heard, I., Juillard, J.-C., Salmon, D., Leruez-Ville, M., Mandelbrot, L., Rouzioux, C., Sicard, D., Zorn, J.-R., Jouannet, P., De Almeida, M.
(2002). Semen alterations in HIV-1 infected men. Hum Reprod
17: 2112-2118
[Abstract][Full Text]
Habasque, C., Aubry, F., Jegou, B., Samson, M.
(2002). Study of the HIV-1 receptors CD4, CXCR4, CCR5 and CCR3 in the human and rat testis. Mol Hum Reprod
8: 419-425
[Abstract][Full Text]
Ghali, W. A., Cornuz, J., McAlister, F. A., Wasserfallen, J.-B., Devereaux, P.J., Naylor, C. D.
(2002). Accelerated publication versus usual publication in 2 leading medical journals. CMAJ
166: 1137-1143
[Abstract][Full Text]
Ghose, R., Liou, L.-Y., Herrmann, C. H., Rice, A. P.
(2001). Induction of TAK (Cyclin T1/P-TEFb) in Purified Resting CD4+ T Lymphocytes by Combination of Cytokines. J. Virol.
75: 11336-11343
[Abstract][Full Text]
Kulkosky, J., Culnan, D. M., Roman, J., Dornadula, G., Schnell, M., Boyd, M. R., Pomerantz, R. J.
(2001). Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood
98: 3006-3015
[Abstract][Full Text]
IPPOLITO, G., GALATI, V., SERRAINO, D., GIRARDI, E.
(2001). The Changing Picture of the HIV/AIDS Epidemic. Ann. N. Y. Acad. Sci.
946: 1-12
[Abstract][Full Text]
Hansasuta, P., Rowland-Jones, S. L
(2001). HIV-1 transmission and acute HIV-1 infection. Br Med Bull
58: 109-127
[Abstract][Full Text]
Englert, Y., Van Vooren, J.-P., Place, I., Liesnard, C., Laruelle, C., Delbaere, A.
(2001). ART in HIV-infected couples: Has the time come for a change of attitude?. Hum Reprod
16: 1309-1315
[Abstract][Full Text]
Dejucq, N., Jegou, B.
(2001). Viruses in the Mammalian Male Genital Tract and Their Effects on the Reproductive System. Microbiol. Mol. Biol. Rev.
65: 208-231
[Abstract][Full Text]
Lo, J. C., Schambelan, M.
(2001). Reproductive Function in Human Immunodeficiency Virus Infection. J. Clin. Endocrinol. Metab.
86: 2338-2343
[Full Text]
Taylor, S., Pereira, A. S
(2001). Antiretroviral drug concentrations in semen of HIV-1 infected men. Sex. Transm. Infect.
77: 4-11
[Abstract][Full Text]
D'Cruz, O. J., Venkatachalam, T. K., Uckun, F. M.
(2001). Thymidine Kinase-Independent Intracellular Delivery of Bioactive Nucleotides by Aryl Phosphate Derivatives of Bromo-Methoxy Zidovudine (Compounds WHI-05 and WHI-07) in Normal Human Female Genital Tract Epithelial Cells and Sperm. Biol. Reprod.
64: 51-59
[Abstract][Full Text]
Levine, A. M., Scadden, D. T., Zaia, J. A., Krishnan, A.
(2001). Hematologic Aspects of HIV/AIDS. ASH Education Book
2001: 463-478
[Abstract][Full Text]
HART, C.A., BEECHING, N.J., DUERDEN, B.I.
(2000). Infections in AIDS: Proceedings of the Sixth Liverpool Tropical School Bayer Symposium on Microbial Diseases held on 6 February 1999. J Med Microbiol
49: 947-967
[Full Text]
BRUGGEMAN, L. A., ROSS, M. D., TANJI, N., CARA, A., DIKMAN, S., GORDON, R. E., BURNS, G. C., D'AGATI, V. D., WINSTON, J. A., KLOTMAN, M. E., KLOTMAN, P. E.
(2000). Renal Epithelium Is a Previously Unrecognized Site of HIV-1 Infection. J. Am. Soc. Nephrol.
11: 2079-2087
[Abstract][Full Text]
Benifla, J.-L., Letur-Konirsch, H., Collin, G., Devaux, A., Kuttenn, F., Madelenat, P., Brun-Vezinet, F., Feldmann, G.
(2000). Safety of cryopreservation straws for human gametes or embryos: a preliminary study with human immunodeficiency virus-1. Hum Reprod
15: 2186-2189
[Abstract][Full Text]
Crowe, S. M., Sonza, S.
(2000). HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J. Leukoc. Biol.
68: 345-350
[Abstract][Full Text]
Brodie, S. J.
(2000). Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease. J. Leukoc. Biol.
68: 351-359
[Abstract][Full Text]
Barroso, P. F., Schechter, M., Gupta, P., Melo, M. F., Vieira, M., Murta, F. C., Souza, Y., Harrison, L. H.
(2000). Effect of Antiretroviral Therapy on HIV Shedding in Semen. ANN INTERN MED
133: 280-284
[Abstract][Full Text]
Bartlett, J. G.
(2000). Update in Infectious Diseases. ANN INTERN MED
133: 285-292
[Full Text]
Marcus, S. F., Avery, S. M., Abusheikha, N., Marcus, N. K., Brinsden, P. R.
(2000). The case for routine HIV screening before IVF treatment: A survey of UK IVF centre policies. Hum Reprod
15: 1657-1661
[Abstract][Full Text]
Choo, E. F., Leake, B., Wandel, C., Imamura, H., Wood, A. J. J., Wilkinson, G. R., Kim, R. B.
(2000). Pharmacological Inhibition of P-glycoprotein Transport Enhances the Distribution of HIV-1 Protease Inhibitors into Brain and Testes. Drug Metab. Dispos.
28: 655-660
[Abstract][Full Text]
Shepard, R. N., Schock, J., Robertson, K., Shugars, D. C., Dyer, J., Vernazza, P., Hall, C., Cohen, M. S., Fiscus, S. A.
(2000). Quantitation of Human Immunodeficiency Virus Type 1 RNA in Different Biological Compartments. J. Clin. Microbiol.
38: 1414-1418
[Abstract][Full Text]
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., Gray, R. H., The Rakai Project Study Group,
(2000). Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1. NEJM
342: 921-929
[Abstract][Full Text]
Cohen, M. S.
(2000). Preventing Sexual Transmission of HIV -- New Ideas from Sub-Saharan Africa. NEJM
342: 970-972
[Full Text]
D'Cruz, O. J., Venkatachalam, T. K., Uckun, F. M.
(2000). Structural Requirements for Potent Human Spermicidal Activity of Dual-Function Aryl Phosphate Derivative of Bromo-Methoxy Zidovudine (Compound WHI-07). Biol. Reprod.
62: 37-44
[Abstract][Full Text]
Dornadula, G., Zhang, H., VanUitert, B., Stern, J., Livornese, L. Jr, Ingerman, M. J., Witek, J., Kedanis, R. J., Natkin, J., DeSimone, J., Pomerantz, R. J.
(1999). Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy. JAMA
282: 1627-1632
[Abstract][Full Text]
Gunthard, H. F., Frost, S. D. W., Leigh-Brown, A. J., Ignacio, C. C., Kee, K., Perelson, A. S., Spina, C. A., Havlir, D. V., Hezareh, M., Looney, D. J., Richman, D. D., Wong, J. K.
(1999). Evolution of Envelope Sequences of Human Immunodeficiency Virus Type 1 in Cellular Reservoirs in the Setting of Potent Antiviral Therapy. J. Virol.
73: 9404-9412
[Abstract][Full Text]
Pomerantz, R. J.
(1999). Primary HIV-1 Resistance: A New Phase in the Epidemic?. JAMA
282: 1177-1179
[Full Text]
Kashuba, A. D. M., Dyer, J. R., Kramer, L. M., Raasch, R. H., Eron, J. J., Cohen, M. S.
(1999). Antiretroviral-Drug Concentrations in Semen: Implications for Sexual Transmission of Human Immunodeficiency Virus Type 1. Antimicrob. Agents Chemother.
43: 1817-1826
[Full Text]
Furtado, M. R., Callaway, D. S., Phair, J. P., Kunstman, K. J., Stanton, J. L., Macken, C. A., Perelson, A. S., Wolinsky, S. M.
(1999). Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy. NEJM
340: 1614-1622
[Abstract][Full Text]
Pomerantz, R. J.
(1999). Residual HIV-1 Disease in the Era of Highly Active Antiretroviral Therapy. NEJM
340: 1672-1674
[Full Text]
(1999). Potent Antiretroviral Therapy Does Not Eliminate HIV from Semen. JWatch Infect. Diseases
1999: 1-1
[Full Text]
(1999). HIV in Semen Despite HAART. AIDS Clin Care
1999: 3-3
[Full Text]
(1998). In HIV Infection, ""Undetectable"" Is Still Infectious. JWatch General
1998: 1-1
[Full Text]
Haase, A. T., Schacker, T. W.
(1998). Potential for the Transmission of HIV-1 despite Highly Active Antiretroviral Therapy. NEJM
339: 1846-1848
[Full Text]